Meta-analysis of randomized trials on GLP1 receptor agonists, exploring the possible association of those classes of drugs, both in diabetes and obesity, with a rare but severe adverse event, optic neuropathy
Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta-analysis of randomised controlled trials / Silverii, Giovanni Antonio; Pala, Laura; Cresci, Barbara; Mannucci, Edoardo. - In: DIABETES, OBESITY AND METABOLISM. - ISSN 1463-1326. - ELETTRONICO. - (2024), pp. 0-0. [10.1111/dom.16076]
Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta-analysis of randomised controlled trials
Silverii, Giovanni Antonio;Pala, Laura;Cresci, Barbara;Mannucci, Edoardo
2024
Abstract
Meta-analysis of randomized trials on GLP1 receptor agonists, exploring the possible association of those classes of drugs, both in diabetes and obesity, with a rare but severe adverse event, optic neuropathy
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Diabetes Obesity Metabolism - 2024 - Silverii - Glucagon‐like peptide 1 GLP1 receptor agonists and risk for ischemic.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
640.75 kB
Formato
Adobe PDF
|
640.75 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
